InvestorsHub Logo
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: midastouch017 post# 725

Thursday, 04/20/2017 7:52:34 AM

Thursday, April 20, 2017 7:52:34 AM

Post# of 3970
Agree
However many cancer biotech make big noise on one cancer drug - early trials - no peer reviewed papers, no externally funded trials

RDHL has all that and few other drugs in P3 trials + decent amount of cash + good margin for dilution
Over and above - a mgmt team that executes professionally to the plan and keeps promises

We may have to wait till mid-2018 for decent appreciation but as long as execution is on target
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News